Lukas B. Been

Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study

Niels J. Harlaar, Marjory Koller, Steven J. de Jongh et al. · ˜The œLancet. Gastroenterology & hepatology · 2016 · 193 citations · Full text

Medicine, Oncology, Surgery +12

Exploiting metabolic acidosis in solid cancers using a tumor-agnostic pH-activatable nanoprobe for fluorescence-guided surgery

Floris J. Voskuil, Pieter J. Steinkamp, Tian Zhao et al. · Nature Communications · 2020 · 175 citations · Full text

Medicine, Cancer Biology, Oncology +17

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)

Koen P. Rovers, Checca Bakkers, Geert A. Simkens et al. · BMC Cancer · 2019 · 111 citations · Full text

Medicine, Oncology, Surgery +14

Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases

Koen P. Rovers, Checca Bakkers, Simon W. Nienhuijs et al. · JAMA Surgery · 2021 · 73 citations · Full text

Medicine, Perioperative Medicine, Surgery +17

Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study

Judith E. K. R. Hentzen, Koen P. Rovers, Hendrien Kuipers et al. · Annals of Surgical Oncology · 2019 · 67 citations · Full text

Medicine, Oncology, Surgery +17